264 related articles for article (PubMed ID: 25641099)
1. Progress in vaccine development.
Moyle PM
Curr Protoc Microbiol; 2015 Feb; 36():18.1.1-18.1.26. PubMed ID: 25641099
[TBL] [Abstract][Full Text] [Related]
2. Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines.
Moyle PM
Biotechnol Adv; 2017; 35(3):375-389. PubMed ID: 28288861
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in adjuvants for vaccines against infectious diseases.
O'Hagan DT; MacKichan ML; Singh M
Biomol Eng; 2001 Oct; 18(3):69-85. PubMed ID: 11566599
[TBL] [Abstract][Full Text] [Related]
4. Modern Vaccine Adjuvant/Formulation--Session 9: Adjuvants.
Dalençon F
Hum Vaccin Immunother; 2013 Sep; 9(9):2013-4. PubMed ID: 23938771
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in vaccine delivery systems.
O'Hagan DT
Curr Drug Targets Infect Disord; 2001 Nov; 1(3):273-86. PubMed ID: 12455401
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in vaccine adjuvants.
Singh M; O'Hagan DT
Pharm Res; 2002 Jun; 19(6):715-28. PubMed ID: 12134940
[TBL] [Abstract][Full Text] [Related]
7. A Focus on Vaccine Development.
Woodland DL
Viral Immunol; 2015; 28(6):303. PubMed ID: 26133044
[No Abstract] [Full Text] [Related]
8. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
Jin Z; Gao S; Cui X; Sun D; Zhao K
Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
[TBL] [Abstract][Full Text] [Related]
9. Progress, challenges and opportunities in fish vaccine development.
Adams A
Fish Shellfish Immunol; 2019 Jul; 90():210-214. PubMed ID: 31039441
[TBL] [Abstract][Full Text] [Related]
10. Fully mobilizing host defense: building better vaccines.
Raychaudhuri S; Rock KL
Nat Biotechnol; 1998 Nov; 16(11):1025-31. PubMed ID: 9831030
[TBL] [Abstract][Full Text] [Related]
11. Vaccine adjuvants: smart components to boost the immune system.
Bastola R; Noh G; Keum T; Bashyal S; Seo JE; Choi J; Oh Y; Cho Y; Lee S
Arch Pharm Res; 2017 Nov; 40(11):1238-1248. PubMed ID: 29027637
[TBL] [Abstract][Full Text] [Related]
12. Controlled delivery of antigens and adjuvants in vaccine development.
Zhao Z; Leong KW
J Pharm Sci; 1996 Dec; 85(12):1261-70. PubMed ID: 8961136
[TBL] [Abstract][Full Text] [Related]
13. [Adjuvants--essential components of new generation vaccines].
Dzierzbicka K; Kołodziejczyk AM
Postepy Biochem; 2006; 52(2):204-11. PubMed ID: 17078510
[TBL] [Abstract][Full Text] [Related]
14. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
[TBL] [Abstract][Full Text] [Related]
15. Targeting the innate immune response with improved vaccine adjuvants.
Pashine A; Valiante NM; Ulmer JB
Nat Med; 2005 Apr; 11(4 Suppl):S63-8. PubMed ID: 15812492
[TBL] [Abstract][Full Text] [Related]
16. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT
Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
[TBL] [Abstract][Full Text] [Related]
17. The path forward.
De Gregorio E
Vaccine; 2015 Jun; 33 Suppl 2():B60-3. PubMed ID: 26022572
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in adjuvant discovery for peptide-based subunit vaccines.
Azmi F; Ahmad Fuaad AA; Skwarczynski M; Toth I
Hum Vaccin Immunother; 2014; 10(3):778-96. PubMed ID: 24300669
[TBL] [Abstract][Full Text] [Related]
19. Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory Capacity.
Zhang R; Kramer JS; Smith JD; Allen BN; Leeper CN; Li X; Morton LD; Gallazzi F; Ulery BD
AAPS J; 2018 Jun; 20(4):73. PubMed ID: 29858738
[TBL] [Abstract][Full Text] [Related]
20. Adjuvants and delivery issues related to immunization: a survey of the recent patent literature.
Mrsny RJ
J Drug Target; 1998; 6(4):243-9. PubMed ID: 9894692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
